Skip to content

Efficacy of the hYpothermic Compression Bandage in the Surgical Wound of Cardiac Devices

Efficacy of the hYpothermic Compression Bandage in the Surgical Wound of Cardiac Devices: A RAndomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05500768
Acronym
EYRA
Enrollment
310
Registered
2022-08-15
Start date
2018-05-01
Completion date
2022-07-31
Last updated
2022-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pocket Hematoma

Keywords

cardiac devices, surgical wound, oral anticoagulation therapy, oral antiplatelet therapy, compression bandage, hypothermic therapy

Brief summary

The aim of this study is to evaluate the efficacy of hypothermic compression bandaging versus conventional compression bandaging, for the prevention of surgical wound hematoma of cardiac implementable electronic devices in patients undergoing chronic oral anticoagulant therapy and/or oral antiplatelet therapy.

Interventions

PROCEDUREhypothermic compression bandage

a compressive bandage is applied for 8 hours to the surgical wound of the cardiac device implants, a frozen prosthesis is added

PROCEDUREConventional compression bandage

a compressive bandage is applied for 8 hours to the surgical wound of the cardiac device implants

Sponsors

Hospital Clinic of Barcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients under oral anticoagulation and/or antiplatelet treatment who were going to undergo implantation of an implanted device cardiac stimulation or generator replacement due to battery depletion

Exclusion criteria

* insertion of drainage in the wound, * non-compliance with the pre-surgical antithrombotic protocol * INR in a high therapeutic range (\>3.5) * Do not follow-up in the same hospital * Coagulation and hemostasis disorders * Replacement of devices due to alterations in the operation unrelated to the battery.

Design outcomes

Primary

MeasureTime frameDescription
Appearance of hematoma10 daysClassification of pocket hematoma according to DeSensi et al.: Grade I: ecchymosis, defined as minor bleeding in the cardiac device pocket, no swelling or pain (watch and wait). Grade II: medium hematoma described as a palpable, bulging mass of \<2cm over the implanted generator. Moderate bleeding in the pocket of the MCP or ICD, causing functional impairment or pain in the area of the heart device Grade III: severe hematoma Determined as a palpable, bulging mass \>2cm. Evacuation is required if it causes tension in the skin with poor tissue perfusion, which is increasing and generates severe pain. Prolongs the patient's hospitalization or readmission for more than 24 hours. Requires immediate discontinuation of OACs or oral antiplatelets

Secondary

MeasureTime frameDescription
Appearance of severe hematoma10 dayssevere hematoma Determined as a palpable, bulging mass \>2cm. Evacuation is required if it causes tension in the skin with poor tissue perfusion, which is increasing and generates severe pain. Prolongs the patient's hospitalization or readmission for more than 24 hours. Requires immediate discontinuation of OACs or oral antiplatelets

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026